119 related articles for article (PubMed ID: 3187951)
21. The interaction of immobilized thrombin with human antithrombin III.
Marciniak E; Gora-Maslak G
Thromb Haemost; 1984 Feb; 51(1):27-31. PubMed ID: 6719385
[TBL] [Abstract][Full Text] [Related]
22. Antithrombin: molecular basis of deficiency.
Bayston TA; Lane DA
Thromb Haemost; 1997 Jul; 78(1):339-43. PubMed ID: 9198176
[TBL] [Abstract][Full Text] [Related]
23. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
[TBL] [Abstract][Full Text] [Related]
24. Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest.
Sas G; Pepper DS; Cash JD
Thromb Diath Haemorrh; 1975 Jun; 33(3):564-72. PubMed ID: 1154312
[TBL] [Abstract][Full Text] [Related]
25. Antithrombin III deficiency.
Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
Rom J Intern Med; 1994; 32(2):119-27. PubMed ID: 7920326
[TBL] [Abstract][Full Text] [Related]
26. Biochemical and functional study of antithrombin III in newborn infants.
McDonald MM; Hathaway WE; Reeve EB; Leonard BD
Thromb Haemost; 1982 Feb; 47(1):56-8. PubMed ID: 7071806
[TBL] [Abstract][Full Text] [Related]
27. Antithrombin III Padua: a "new" congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease.
Girolami A; Pengo V; Cappellato G; Vianello C; Procidano M; Cartei C
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):98-111. PubMed ID: 6192061
[TBL] [Abstract][Full Text] [Related]
28. Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin.
Ireland H; Lane DA; Thompson E; Walker ID; Blench I; Morris HR; Freyssinet JM; Grunebaum L; Olds R; Thein SL
Br J Haematol; 1991 Sep; 79(1):70-4. PubMed ID: 1911389
[TBL] [Abstract][Full Text] [Related]
29. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
Bohner J; von Pape KW; Blaurock M
Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
Meddahi S; Bara L; Fessi H; Samama MM
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
[TBL] [Abstract][Full Text] [Related]
31. High molecular weight forms of antithrombin III complexes in blood.
Marciniak E; Gora-Maslak G
Thromb Haemost; 1983 Feb; 49(1):32-6. PubMed ID: 6845270
[TBL] [Abstract][Full Text] [Related]
32. An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy.
Aiach M; François D; Priollet P; Capron L; Roncato M; Alhenc-Gelas M; Fiessinger JN
Br J Haematol; 1987 Aug; 66(4):515-22. PubMed ID: 3663508
[TBL] [Abstract][Full Text] [Related]
33. Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.
Okajima K; Abe H; Wagatsuma M; Okabe H; Takatsuki K
Am J Hematol; 1995 Jan; 48(1):12-8. PubMed ID: 7832187
[TBL] [Abstract][Full Text] [Related]
34. Fate of thrombin and thrombin-antithrombin-III complex adsorbed to a heparinized biomaterial: analysis of the enzyme-inhibitor complexes displaced by plasma.
Hatton MW; Rollason G; Sefton MV
Thromb Haemost; 1983 Dec; 50(4):873-7. PubMed ID: 6198746
[TBL] [Abstract][Full Text] [Related]
35. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
[TBL] [Abstract][Full Text] [Related]
36. Hepatocyte uptake of alpha 1-proteinase inhibitor-trypsin complexes in vitro: evidence for a shared uptake mechanism for proteinase complexes of alpha 1-proteinase inhibitor and antithrombin III.
Fuchs HE; Michalopoulos GK; Pizzo SV
J Cell Biochem; 1984; 25(4):231-43. PubMed ID: 6334690
[TBL] [Abstract][Full Text] [Related]
37. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.
Turk B; Brieditis I; Bock SC; Olson ST; Björk I
Biochemistry; 1997 Jun; 36(22):6682-91. PubMed ID: 9184148
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
[TBL] [Abstract][Full Text] [Related]
39. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update.
Rodgers GM
Thromb Haemost; 2009 May; 101(5):806-12. PubMed ID: 19404531
[TBL] [Abstract][Full Text] [Related]
40. Antithrombin-III-Hamilton: a gene with a point mutation (guanine to adenine) in codon 382 causing impaired serine protease reactivity.
Devraj-Kizuk R; Chui DH; Prochownik EV; Carter CJ; Ofosu FA; Blajchman MA
Blood; 1988 Nov; 72(5):1518-23. PubMed ID: 3179438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]